A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT00104195
Collaborator
(none)
127
1
122
1

Study Details

Study Description

Brief Summary

The purpose of this trial is to study how teens with and without an anxiety disorder make decisions.

This is a brain imaging study using functional magnetic resonance imaging (fMRI) in adolescents between the ages of 13 and 17.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Preliminary analyses of behavioral data showed no group differences in response times during the decision-making games. However, behavioral ratings of certainty during the task showed differences between groups. Anxiety-disordered participants indicated lower levels of certainty during the most uncertain conditions of the task (p < .05). This difference was consistent with the study hypothesis. Within-subjects analyses of the decision-making tasks showed that subjects responded as expected. Reaction times (RT) during uncertain conditions of the HiLo-Game were significantly longer than during more certain conditions (p = .001). Diary Task RTs for rating ambiguous situations were significantly longer than ratings of unambiguous situations (p = .019). Preliminary Analyses showed a significant correlation between Intolerance of Uncertainty (IU) and RT during the Marble Task (r = -0.54, p < .05). Preliminary analysis also showed significant correlation between ratings of level of anxiety during the diary task and IU, IS, MASC and the child version of the SCARED. These preliminary results were not submitted for publication.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    127 participants
    Observational Model:
    Case-Control
    Official Title:
    Decision-Making Processes and Brain Function in Anxiety-Disordered and Non-Anxious Youth
    Study Start Date :
    Feb 1, 2004
    Actual Primary Completion Date :
    Apr 1, 2014
    Actual Study Completion Date :
    Apr 1, 2014

    Outcome Measures

    Primary Outcome Measures

    1. Intolerance of Uncertainty [at time of assessment/enrollment]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Must meet diagnostic criteria for Generalized Anxiety Disorder, Separation Anxiety Disorder or Social Phobia, OR must be free of medical, psychiatric, neurologic conditions and learning disorders (healthy controls)

    • Sufficient intelligence to understand the study and provide truly informed consent; will be determined by educational history

    Exclusion Criteria:
    • Having any major medical conditions that may interfere with interpretation of results or be associated with risk in an MRI environment (history of metal implants, or contraindications to MRI scanning for research purposes, including pregnancy)

    • Current evidence of Autism, Major Depression, Substance Abuse, Obsessive Compulsive Disorder, Post-traumatic Stress Disorder, Panic Disorder, Tic Disorders, significant suicidality, lifetime history of psychosis or mania.

    • Estimated Full-Scale IQ below 80

    • Inability or unwillingness to remain still during scanning

    • Inability or unwillingness to provide assent

    • Absence of signed consent by parent or legal guardian

    • Current history of sexual or physical abuse in the family, or past sexual or physical abuse if there is ongoing Department of Social Services (DSS) involvement

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 New York University's Child Study Center New York New York United States 10016

    Sponsors and Collaborators

    • NYU Langone Health

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    F. Xavier Castellanos, Professor, NYU Langone Health
    ClinicalTrials.gov Identifier:
    NCT00104195
    Other Study ID Numbers:
    • H11610
    First Posted:
    Feb 24, 2005
    Last Update Posted:
    Apr 16, 2014
    Last Verified:
    Apr 1, 2014
    Keywords provided by F. Xavier Castellanos, Professor, NYU Langone Health
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 16, 2014